Related references
Note: Only part of the references are listed.Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines
Lambert Bodewein et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Improving oral drug bioavailability with polycations?
Jessica D. Schulz et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer
Yogesh K. Katare et al.
MOLECULAR PHARMACEUTICS (2015)
Enhancement of Solubility and Bioavailability of Candesartan Cilexetil using Natural P-Glycoprotein Inhibitors
Noor Ahmad Zulal et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2015)
Dendrimers - from organic synthesis to pharmaceutical applications: an update
Rahul S. Kalhapure et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2015)
Water-soluble TRIS-terminated PAMAM dendrimers: microwave-assisted synthesis, characterization and Cu(II) intradendrimer complexes
Ali Serol Erturk et al.
RSC ADVANCES (2015)
Microwave assisted synthesis of Jeffamine cored PAMAM dendrimers
Ali S. Erturk et al.
EUROPEAN POLYMER JOURNAL (2014)
The evaluation of the biomedical effectiveness of poly(amido)amine dendrimers generation 4.0 as a drug and as drug carriers: A systematic review and meta-analysis
Marian Jedrych et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Cytotoxicity and in vitro characterization studies of synthesized Jeffamine- cored PAMAM dendrimers
Kivilcim Ozturk et al.
JOURNAL OF MICROENCAPSULATION (2014)
Bioapplications of poly(amidoamine) (PAMAM) dendrimers in nanomedicine
Negar Taghavi Pourianazar et al.
JOURNAL OF NANOPARTICLE RESEARCH (2014)
Dendrimer as nanocarrier for drug delivery
Prashant Kesharwani et al.
PROGRESS IN POLYMER SCIENCE (2014)
Charge affects the oral toxicity of poly(amidoamine) dendrimers
Giridhar Thiagarajan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin
Lin Gu et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2013)
Mixed solvency concept in reducing surfactant concentration of self-emulsifying drug delivery systems of candesartan cilexetil using D-optimal mixture design
Chandna Chandan et al.
ASIAN JOURNAL OF PHARMACEUTICS (2013)
Dendrimers in biomedical applications-reflections on the field
Soenke Sevenson et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats
Kamil Karolczak et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Khaled Greish et al.
NANOTOXICOLOGY (2012)
Kinetic analysis of the interaction between poly(amidoamine) dendrimers and model lipid membranes
Venkataswarup Tiriveedhi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Interaction of cationic phosphorus dendrimers (CPD) with charged and neutral lipid membranes
Maksim Ionov et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state
Alaa' A. Al Omari et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers
Qingxing Xu et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Dendrimer toxicity: Let's meet the challenge
Keerti Jain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications
Venkata K. Yellepeddi et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Folate and Folate-PEG-PAMAM Dendrimers: Synthesis, Characterization, and Targeted Anticancer Drug Delivery Potential in Tumor Bearing Mice
Prateek Singh et al.
BIOCONJUGATE CHEMISTRY (2008)
Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability
Narendra K. Jain et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Dendrimers for enhanced drug solubilization
Sonke Svenson et al.
NANOMEDICINE (2008)
Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes
Bharathi Devarakonda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Characterization by fourier transform infrared spectroscopy (FT-IR) and 2D IR correlation spectroscopy of PAMAM dendrimer
Maria-Cristina Popescu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2006)
Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement
U Gupta et al.
BIOMACROMOLECULES (2006)
Candesartan in heart failure
Toni L. Ripley et al.
CLINICAL INTERVENTIONS IN AGING (2006)
Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins
B Devarakonda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers
YY Cheng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Dendrimers in drug research
U Boas et al.
CHEMICAL SOCIETY REVIEWS (2004)
Solubility enhancement of indomethacin with poly(amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats
AS Chauhan et al.
JOURNAL OF DRUG TARGETING (2004)
Dendrimers in solution: Insight from theory and simulation
M Ballauff et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine
B Devarakonda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Dendritic molecular capsules for hydrophobic compounds
MT Morgan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin
AS Chauhan et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Determination of the intrinsic proton binding constants for poly(amidoamine) dendrimers via potentiometric pH titration
YH Niu et al.
MACROMOLECULES (2003)
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
P Kolhe et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Microscopic protonation equilibria of poly(amidoamine) dendrimers from macroscopic titrations
D Cakara et al.
MACROMOLECULES (2003)
Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives
AE Beezer et al.
TETRAHEDRON (2003)
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
R Jevprasesphant et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
R Esfand et al.
DRUG DISCOVERY TODAY (2001)
Angiotensin II type 1 receptor blockers
M Burnier
CIRCULATION (2001)
Effect of protonation and PAMAM dendrimer size on the complexation and dynamic mobility of 2-naphthol
MH Kleinman et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2000)
Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo
N Malik et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
